<p>The mice immunized with recMAGE-A3+AS15 (1 µg of antigen) were followed up to Day 112. On Days 77 and 112, standard errors of the mean are shown and the number of tumor-free mice is indicated for each group. Statistical comparisons of the mean tumor size of each group with that the TC1-MAGE-A3 (100%) group on Days 77 and 112 are shown (* = p<0.01; ** = p<0.001; NS = not significant). Red arrow: day of challenge.</p
<p>Mice were treated with 10<sup>7</sup> PFU of Ad5, Ad5T122, or injected with a corresponding volum...
<p>(A and B) Protection against pre-injected tumors. Four hours after lethal CT26 tumor cell challen...
Tumor volume was evaluated at the indicated days. As shown, tumor burden was dramatically less in Se...
<p>The mice (n = 5) were immunized with recMAGE-A3 (10 µg of antigen) formulated with different immu...
<p>In cell depletion experiments, control isoptypes (Ig) similar to the antibody used to deplete T c...
<p>A. Study design and sample size (CB6F1 mice) at the different steps are shown. Immunizations were...
<p>Mice were subcutaneously immunized with PBS or TcdB-exposed CT26 cells (TcdB). In some experiment...
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
a) Kaplan-Meier survival analysis. b) Change in tumor growth over time as determined by caliper meas...
<p>Mice were immunized once with PBS or 2×10<sup>5</sup> TcdB-exposed B16-F10 cells per mouse before...
<p>Tumor-bearing mice were treated with 10, 25 or 50 mg/kg of mAb AFS98 or PBS, IP, starting from da...
<p>Mice were injected s.c. with B16 cells on day 0. Mice were immunized s.c. with 1x10<sup>6</sup> D...
<p>At 10 weeks of age, MMTV-PyMT mice were treated with 50 mg/kg of mAb AFS98, control rat IgG or PB...
<p>Mice (n = 10/group) received tumor cells and were immunized twice with DNA (empty vector pTHkan, ...
<p>Mice were immunized with three doses of PBS/2M urea (PBS) or E6E7 in intervals of 14 days. Mice w...
<p>Mice were treated with 10<sup>7</sup> PFU of Ad5, Ad5T122, or injected with a corresponding volum...
<p>(A and B) Protection against pre-injected tumors. Four hours after lethal CT26 tumor cell challen...
Tumor volume was evaluated at the indicated days. As shown, tumor burden was dramatically less in Se...
<p>The mice (n = 5) were immunized with recMAGE-A3 (10 µg of antigen) formulated with different immu...
<p>In cell depletion experiments, control isoptypes (Ig) similar to the antibody used to deplete T c...
<p>A. Study design and sample size (CB6F1 mice) at the different steps are shown. Immunizations were...
<p>Mice were subcutaneously immunized with PBS or TcdB-exposed CT26 cells (TcdB). In some experiment...
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
a) Kaplan-Meier survival analysis. b) Change in tumor growth over time as determined by caliper meas...
<p>Mice were immunized once with PBS or 2×10<sup>5</sup> TcdB-exposed B16-F10 cells per mouse before...
<p>Tumor-bearing mice were treated with 10, 25 or 50 mg/kg of mAb AFS98 or PBS, IP, starting from da...
<p>Mice were injected s.c. with B16 cells on day 0. Mice were immunized s.c. with 1x10<sup>6</sup> D...
<p>At 10 weeks of age, MMTV-PyMT mice were treated with 50 mg/kg of mAb AFS98, control rat IgG or PB...
<p>Mice (n = 10/group) received tumor cells and were immunized twice with DNA (empty vector pTHkan, ...
<p>Mice were immunized with three doses of PBS/2M urea (PBS) or E6E7 in intervals of 14 days. Mice w...
<p>Mice were treated with 10<sup>7</sup> PFU of Ad5, Ad5T122, or injected with a corresponding volum...
<p>(A and B) Protection against pre-injected tumors. Four hours after lethal CT26 tumor cell challen...
Tumor volume was evaluated at the indicated days. As shown, tumor burden was dramatically less in Se...